← Open Payments lookup

VIMALA RAVI: Open Payments

NPI 1811437296 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$945 in 48 payments from 10 companies in 2025. Trend: 2023 $910 · 2024 $1,899 · 2025 $945

Food & beverage: $945
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.8$268
Novo Nordisk Inc9$185
Lilly USA, LLC13$155
AstraZeneca Pharmaceuticals LP5$104
Boehringer Ingelheim Pharmaceuticals, Inc.5$101
Esperion Therapeutics, Inc.3$43
Astellas Pharma US Inc2$31
Otsuka America Pharmaceutical, Inc.1$23
SHIELD THERAPEUTICS INC1$18
Sumitomo Pharma America, Inc.1$17

Products named: Kerendia, JARDIANCE, FARXIGA, Ozempic, MOUNJARO, Wegovy, NEXLETOL, KISUNLA.

Industry payments across TX — which companies pay providers there.